VC-backed Arcadia Biosciences files for $86m IPO

Arcadia Biosciences, which wants to list on Nasdaq, is backed by BASF Venture Capital, Mandala Capital, CMEA Ventures and Saints Capital among others.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.